Health
GLP-1s drive hair loss market
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary hair thinning and prepared for the worst.
But it would take about a year before she began noticing her hair falling out in clumps. Cooper said it was especially shocking because she has always had thick hair.
“I was really hoping it wouldn’t happen,” Cooper, 29, told CNBC. “What my provider had told me is that since you’re on the medication that’s allowed you to lose weight at a faster rate, that’s what can cause hair loss.”
Desperate to counteract the side effect, Cooper said she began prioritizing protein in her diet, taking vitamins intended to help her hair and investing in haircare products meant to stimulate the scalp to foster growth.
She’s one of a growing number of GLP-1 users experiencing temporary hair loss from the drugs, creating a new market for hair treatment products amid the weight-loss drug craze.
Cooper took to social media for support, where she found scores of other GLP-1 users experiencing the same thing. While the discourse was less frequent at the beginning of her weight-loss journey, the rise of GLP-1s has meant that more people are flocking to her page to commiserate and strategize.
“There has been an increase of people wanting to know how to tackle it, but it’s also a lot of people who are wanting to know how they can possibly prevent it, and that’s just something that I don’t have the answer to,” Cooper said.
According to Gallup, the use of GLP-1 drugs has more than doubled since early 2024. The KFF Health Tracking Poll found that roughly one in every eight U.S. adults, or nearly 13%, are currently taking a GLP-1 drug.
By 2030, JPMorgan estimates that roughly 25 million Americans will be on a GLP-1, up from just 5 million in 2023.
Profit amid loss
Many GLP-1 users have seen significant results in losing weight. But the drugs come with a multitude of side effects, too.
Zepbound, manufactured by pharmaceutical giant Eli Lilly, advertises common side effects on its website that include hair loss, nausea and vomiting, fatigue and more. Mounjaro, also a Lilly drug, warns of similar side effects, along with Novo Nordisk’s Ozempic. Wegovy also includes hair loss in its possible side effects.
It’s a risk that’s common with any type of significant weight loss because of the body’s changes, according to Dr. Heather Woolery-Lloyd, a dermatologist and the chief medical advisor for haircare brand Nutrafol.
“When you are losing weight, either through a GLP-1 or any other type of weight loss, you may be taking in less nutrients, less protein, and the weight loss itself can be a stressor,” she told CNBC.
Those consumers have been increasingly seeking out solutions to ease the physical process, according to Circana. The Chicago-based market research firm estimates that GLP-1 households spend approximately 30% more on beauty products than non-GLP-1 households.
“Hair loss solutions continue to be a standout growth segment in hair care, sustained by prolonged consumer stress since the pandemic and GLP‑1 medication usage emerging as an incremental tailwind,” said Larissa Jensen, Circana’s beauty industry advisor. “Many GLP‑1 users report temporary hair shedding, which is translating into increased demand for at‑home growth treatments, scalp serums, and supplements.”
The hit to a GLP-1 user’s self-confidence from the hair loss can mean even more stress, according to Woolery-Lloyd.
In her practice, she said she’s seen a noticeable increase in patients coming in specifically with hair thinning concerns, many of them because of GLP-1 side effects. Woolery-Lloyd said the last time she saw an influx of patients with these concerns was during the pandemic, due to unexpected amounts of stress on the body.
The hair loss from GLP-1s is one of the most significant side effects that the beauty industry is watching, according to Audrey Depraeter-Montacel, Accenture’s global beauty industry lead.
“GLP-1s have not just changed the way people lose weight, but the way consumers expect beauty and personal care to address the situation,” she told CNBC, adding that it’s not a “one size fits all” solution.
Depraeter-Montacel called the size of the GLP-1 market “unprecedented” and said the business opportunity for the hair treatment market with this growing population sets the scene for innovation.
“On the life science side, we are seeing a lot of pharma brands raising funds to go after innovation and new solutions,” she said. “So a lot of money has been raised in the name of this opportunity, which I think confirmed that there is definitely a commercial opportunity here as investors put dollars in this on both sides.”
Consumers who will be buying into the GLP-1 hair treatment market are also sticking around, Depraeter-Montacel said. Because hair treatment products often take a few months to begin showing results, these customers are expected to be highly loyal.
Tapping into the market
Brands are taking notice. In early April, Ulta CEO Kecia Steelman told Yahoo Finance that the company is seeing more consumers buying hair treatment products as part of the GLP-1 craze.
Redken, a haircare company owned by L’Oreal, created an entire hair treatment line specifically for consumers with thin hair called the Acidic Grow Full System.
“We wanted to ensure the Acidic Grow Full System range was tested on this specific population of GLP-1 users, as they may have unique hair care needs,” Mounia Tahiri, Redken’s U.S. general manager, told CNBC. ”[It] was tested on current GLP-1 users who, when using the products, immediately noticed their hair looked fuller and felt thicker.”
Tahiri said the company also saw a rise in Google searches for hair loss and weight-loss drugs and plans to continue innovating its hair treatment products as the GLP-1 population grows.
Nutrafol CEO Cindy Gustafson told CNBC the haircare brand is similarly seeing increased demand for hair health products.
“While we don’t break out performance tied to GLP-1 use, growth overall is being driven by increased awareness and a shift toward personalized, clinically supported solutions,” she said.
Gustafson said the company expects this growth to continue as more people begin taking GLP-1s and searching for products to prevent or counteract hair thinning.
KeraFactor, another scalp health company, told CNBC that it’s seeing 100% growth year-over-year in its direct-to-consumer store because of an increased interest from GLP-1 users.
“We saw a lot of [hair loss] during Covid, so that was actually the first kind of spike of patients that came to KeraFactor, and then after Covid, it kind of settled,” Lauren Bartholomeusz, the company’s chief commercial officer, told CNBC. “And then now, we’re seeing that rise again with the GLP-1 craze.”
Bartholomeusz said KeraFactor has shifted the way it treats patients to now come from a more preventative perspective to get ahead of the possible hair loss while taking the drugs.
For Cooper, the 29-year-old GLP-1 user, there may be light at the end of the tunnel.
She’s experimented with many hair products over the past three years of taking weight-loss drugs, hoping for her hair to return to its former thickness.
“I’ve been paying more attention to it for about a year, and I’ve been noticing it’s returned,” Cooper said. “A lot of people, they get nervous when they have the hair shedding, because it’s like, ‘Oh, I’m going to be bald for eternity.’ But the hair comes back, so that was what let me have peace with it. But it was scary.”
CNBC
Health
Emirates Specialty Hospital Expands Cancer Care Services in Dubai with Opening of Dedicated Chemotherapy Unit
New facility at Dubai Healthcare City aims to improve access to specialised cancer treatment, bringing personalised oncology care and medical expertise together under one roof
Dubai, UAE: Emirates Specialty Hospital in Dubai Healthcare City has announced the opening of a dedicated chemotherapy unit within its Emirates Oncology Centre, marking a significant expansion of its cancer care services and strengthening access to specialised oncology treatment for patients in Dubai.
The newly established unit has been designed to provide chemotherapy treatments in a dedicated clinical setting, with an emphasis on patient safety, individualised treatment plans and continuous medical support throughout the cancer care journey.
The opening comes as healthcare providers increasingly recognise the importance of delivering cancer treatment through a coordinated, multidisciplinary approach that addresses not only the disease itself but also the physical and emotional challenges patients may experience during treatment.
For many cancer patients, chemotherapy involves repeated hospital visits, ongoing medical assessments and careful monitoring of treatment responses and potential side effects. Access to a specialised facility supported by experienced oncology professionals can play an important role in ensuring continuity of care and helping patients navigate what is often a complex and demanding treatment journey.
Bringing specialised cancer treatment closer to patients
The Emirates Oncology Centre brings together medical expertise and patient-focused services to support individuals undergoing cancer treatment.
The oncology services are supervised by Prof. Dr. Marwan Ghosn, Consultant Medical Oncologist, and Dr. Mohamed Elbassyouny Alawy, Specialist Medical Oncology, who oversee the delivery of specialised oncology care.
Treatment plans are developed according to each patient’s diagnosis, medical condition and individual clinical needs, with an emphasis on evidence-based medical practice, careful monitoring and appropriate supportive care.
The dedicated chemotherapy unit forms part of the hospital’s broader strategy to strengthen its specialised medical services while maintaining high standards of clinical quality and patient safety.
Cancer care goes beyond chemotherapy
While chemotherapy remains an important treatment option for many types of cancer, oncology care increasingly requires a comprehensive approach that considers each patient’s overall health, treatment tolerance and quality of life.
Patients receiving chemotherapy may experience a range of challenges, including fatigue, nausea, changes in appetite and other treatment-related effects that require ongoing medical attention.
The Emirates Oncology Centre places particular emphasis on supporting patients throughout these challenges, with treatment decisions guided by clinical assessment and individual patient needs.
The approach reflects a growing shift in cancer care towards personalised treatment, where medical teams consider the characteristics of the disease alongside the patient’s health, circumstances and treatment goals.
Equally important is the need for clear communication between doctors, patients and their families, particularly when discussing treatment options, expected outcomes and possible side effects.
By placing patients at the centre of clinical decision-making, the hospital aims to provide a treatment experience built around medical expertise, informed choices and compassionate care.
Strengthening Dubai’s specialised healthcare services
The opening of the chemotherapy unit represents another step in Emirates Specialty Hospital’s ongoing efforts to expand its clinical capabilities and provide comprehensive healthcare services within Dubai Healthcare City.
As demand for specialised healthcare continues to evolve, the availability of dedicated oncology facilities is increasingly important in supporting timely access to treatment and ensuring patients can receive appropriate care within an established hospital environment.
The hospital said the new unit reflects its commitment to investing in specialised medical services and improving the overall patient experience through coordinated care, experienced healthcare professionals and a strong focus on clinical safety.
With the opening of the dedicated chemotherapy unit, Emirates Specialty Hospital aims to further strengthen its role in providing specialised cancer care in Dubai, offering patients and their families access to personalised treatment and medical support at every stage of their journey.
For more information please visit our website : Emirates Hospitals Dubai – Best Hospital in Dubai, Top Rated
About Emirates Specialty Hospital
Located in Dubai Healthcare City, Emirates Specialty Hospital is a multidisciplinary healthcare facility providing a range of specialised medical and surgical services. The hospital continues to expand its clinical capabilities, with a focus on medical expertise, patient-centred care and high standards of healthcare quality and safety.
Health
When Rheumatoid Arthritis Threatened Her Independence: How the Right Diagnosis Helped Her Get Her Life Back
For a 45-year-old UAE resident, persistent pain and swelling turned out to be rheumatoid arthritis. Early recognition and treatment helped her return to work, driving and the family life she feared she might lose.
For Dilini Ayesha, driving is much more than a job.
For the 45-year-old mother of two, who has lived in the UAE for 16 years, driving is a profession she has built her independence around. For the past eight years, she has worked as a driving instructor at Emirates Driving Institute, including as a VIP instructor training people to drive larger vehicles and four-wheel drives.
She is also a mother to an adopted daughter and a five-year-old son.
So when unexplained pain and swelling suddenly began affecting her hands, her greatest fear was not simply the pain itself. It was the possibility that rheumatoid arthritis might prevent her from continuing to work and caring for her family independently.
Her journey began with what appeared to be an unrelated injury.
In December 2024, Dilini fell and injured her knee while helping a recovery truck load her vehicle. Several months later, she suffered another fall at home, causing a more significant knee injury. Following an MRI, she underwent ACL reconstruction and meniscal repair and spent around two and a half months recovering.
She was looking forward to returning to her normal routine.
But shortly after returning to work, she developed severe swelling and pain in both hands.
“At first, I thought it might be connected to my surgery or that it would settle down,” Dilini recalls. “But the pain kept getting worse.”
She was prescribed different painkillers, but the symptoms continued to progress. She eventually found herself struggling to grip a steering wheel or use her hands normally.
“For me, the pain felt like 15 out of 10,” she says. “I know that isn’t a normal pain scale, but that is honestly how it felt.”
The physical pain was accompanied by something else: fear.
“What if I can’t drive anymore? What if I can’t work anymore? How will I take care of my children?”
It was at this point that Dilini was referred to Dr Muhammad Azhar Abdullah, Consultant Rheumatologist at NMC Royal Hospital Sharjah.
Rather than assuming that the symptoms were simply part of her recovery from the knee injury, Dr Azhar investigated the underlying cause.
Clinical assessment and blood investigations pointed towards rheumatoid arthritis (RA) — a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the joints, causing inflammation, pain and swelling.
“Rheumatoid arthritis is not simply wear and tear of the joints,” explains Dr Azhar. “It is an inflammatory autoimmune disease, and if the inflammation remains uncontrolled, it can progressively damage the joints. It can also be associated with problems affecting other parts of the body.”
For Dilini, receiving a diagnosis of rheumatoid arthritis finally provided an explanation for what was happening to her body.
“Having an answer was important to me,” she says. “When you don’t know what is happening to your own body, the fear becomes even bigger.”
Why recognising rheumatoid arthritis early matters
Rheumatoid arthritis can present differently from person to person, but persistent joint swelling, prolonged morning stiffness, pain and difficulty moving the affected joints should not simply be dismissed as ageing, overuse or ordinary aches and pains.
One important distinction is that not all arthritis is rheumatoid arthritis. Osteoarthritis, gout, psoriatic arthritis and other inflammatory rheumatic diseases can produce joint symptoms, but their causes and treatments are different.
That is why identifying the underlying condition matters.
In Dilini’s case, identifying rheumatoid arthritis allowed treatment to be started without waiting for further progression.
“Once we identified that she was dealing with rheumatoid arthritis, the priority was to control the inflammation and prevent further problems,” says Dr Azhar. “The aim of treatment in rheumatoid arthritis is not simply to reduce pain temporarily. It is to control the underlying disease, protect joint function and help the patient maintain her quality of life and independence.”
Her improvement was gradual rather than an overnight transformation.
Over the following weeks, the inflammation and pain began to settle. Her hand function and mobility improved, and by around the third week, Dilini was able to return to work.
She could once again hold the steering wheel.
She could work.
And she could return home and care for her children independently.
“I felt like I had been given my life back,” she says.
When treating rheumatoid arthritis means protecting a person’s dreams
This year’s World Arthritis Day campaign theme, “Achieve Your Dreams,” highlights the aspirations and goals of people living with rheumatic and musculoskeletal diseases. For Dilini, her dream was not complicated.
It was to continue working, driving and being there for her children.
Her experience demonstrates why early recognition of rheumatoid arthritis matters. The disease can cause permanent joint damage if inflammation remains uncontrolled, while it may also have effects beyond the joints.
“Patients sometimes wait because they think joint pain is something they simply have to live with,” says Dr Azhar. “Persistent swelling, prolonged morning stiffness or unexplained joint pain deserve medical assessment, particularly when symptoms are affecting everyday activities. The earlier we identify rheumatoid arthritis, the earlier we can discuss appropriate treatment and work towards controlling the disease.”
Today, Dilini is back behind the wheel and back to the life she feared she might lose.
“I am driving. I am working. I am taking care of my children,” she says. “I don’t take any of those things for granted anymore.”
Her message to others is simple:
“If you are experiencing unexplained pain, swelling or stiffness, please don’t ignore it. Get yourself checked. Sometimes, getting the right answer can be the beginning of getting your life back.”
For Dilini, that diagnosis did more than explain her symptoms.
It helped protect the life she had worked so hard to build.
Dr Muhammad Azhar Abdullah is Consultant Rheumatologist at NMC Royal Hospital Sharjah.
Health
Saudi German Hospital Dubai Launches Mental Health and Wellness Center for Children and Adolescents
Saudi German Hospital Dubai Launches Mental Health and Wellness Center for Children and Adolescents
A comprehensive care system aligned with the Dubai Mental Wealth Framework
Dubai, United Arab Emirates – 10 October 2026
Saudi German Hospital Dubai has launched the Saudi German Mental Health & Wellness Hub, unveiled at an evening event at Raffles The Palm on 9 October 2026. The Hub is designed to end the fragmented experience many families face when navigating mental healthcare by bringing psychiatrists, psychologists and relevant hospital specialties together around a single, shared plan for each patient.
The Hub is designed as an ecosystem of comprehensive care, connecting prevention, early identification, specialist assessment, treatment, family support and ongoing follow-up through one coordinated plan for each patient. The model aligns with Dubai’s Mental Wealth Framework and its emphasis on prevention, early intervention, access to care and community wellbeing.
Child and adolescent mental health sits at the centre of the model. The Hub operates on the conviction that a child’s difficulties cannot be understood in isolation from their home, classroom and development, and that care should reflect all three.
Supporting children and families from the start
Services available at launch for children and adolescents include comprehensive psychiatric and psychological assessment; support for emotional, behavioural and developmental concerns; psychoeducational assessments for learning difficulties; ADHD assessment and management; and ASD assessment with individualised support across communication, social interaction and behaviour. Parent guidance and, where appropriate and with consent, collaboration with schools are built into the pathway — not offered as an afterthought.
Mental health care across every stage of life
Adult and older adult services include psychiatric assessment, medication management and individual therapy; treatment for depression, anxiety, OCD and related conditions; trauma-informed care for PTSD; geriatric psychiatry; couples and family counselling; addiction assessment and treatment; and community mental health education.
Speech and language therapy, occupational therapy and further developmental programmes are in development and will be confirmed once clinical staffing and readiness are in place.
Dr Ahmed Eissa, Group CEO of Saudi German Health UAE, said: “Many families come to us after years of seeing different specialists who never spoke to each other. A child gets one diagnosis here, a referral there, and the parents are left to hold it all together. We designed this Hub as an ecosystem of comprehensive care, bringing psychiatry, psychology and related specialties together around one plan, from early identification to treatment, follow-up and family support. This approach supports the objectives of Dubai’s Mental Wealth Framework and helps more people access coordinated mental healthcare at every stage of life.”
The Hub’s clinical team brings expertise in adult, child and adolescent, and addiction psychiatry; clinical psychology; psychoeducational and neurodevelopmental assessment; psychotherapy; and couples and family counselling. Team members carry international experience from the UAE, Australia, Saudi Arabia and Egypt, with a specific commitment to culturally and linguistically responsive care.
As part of Saudi German Hospital Dubai, the Hub has direct access to other medical specialties when physical and mental health needs intersect — an advantage that standalone clinics cannot easily replicate.
________________________________________
About Saudi German Health UAE
Saudi German Health UAE is part of the regional Saudi German Health network, providing hospital, multidisciplinary and specialist medical services through its facilities in Dubai, Sharjah and Ajman. Guided by its Caring Like Family philosophy, the group places people and their needs at the centre of the healthcare experience.
For more information or to book an appointment
www.saudigerman.com/psychiatry-mental-health-clinics/
Call: 800 2211
Media Contact
Awareness Marketing Management DWC LLC
Mourad Alsayed
murad.mustafa@awarenessupr.com | +971 58 814 4155
-
politics6 months agoAraghchi, Oman Sultan discuss transit, stability in Muscat
-
UAE10 months agoUAE’s café culture keeps growing despite price pressure
-
Entertainment9 months agoNetflix to Livestream BTS Comeback Concert
-
Discover9 months agoIs February 2026 really a once-in -283-years MiracleIn?
-
Football10 months agoAlgeria, Burkina Faso, Côte d’Ivoire win AFCON 2025 openers
-
Health10 months agoNMC Royal Hospital, Khalifa City, performs rare wrist salvage, restoring function for young patient
-
Health10 months agoBascom Palmer Eye Institute Abu Dhabi and Emirates Society of Ophthalmology Sign Strategic Partnership Agreement
-
Health11 months agoEmirates Society of Colorectal Surgery Concludes the 3rd International Congress Under the Leadership of Dr. Sara Al Bastaki
